Navigation Links
The Avanta Soft Skeletal Hand Implant System

ProductsThe Avanta Soft Skeletal Hand Implant System
Company Small Bone Innovations, Inc.
Item The Avanta Soft Skeletal Hand Implant System
Features 
  • The Avanta MCP and PIP Soft Skeletal Implants constructed of Silflex II advanced elastomer, offer post-surgical results unavailable in any other finger joint implants.
  • The only silicone product line which accommodates the specific, unique biomechanics and anatomy of the MCP and PIP joints.
  • Each product has supporting instruments consisting of color coded broaches, trials, and package labeling for convenient accurate identification.
    • Description Arthritis of the hand can make simple motions such as gripping an object or turning a key painful, if not impossible. The Avanta Soft Skeletal Hand Implants can help alleviate the disabling effects of this disease. By incorporating advanced materials, extensive clinical experience, and joint-specific design features these implants offer todays hand surgeon advantages not currently available in other finger joints. Avanta also offers a Preflex™ Finger Joint Implant - angled at 30-degress to anatomically simulate the MCP joint at rest.
    Info Small Bone Innovations, Inc.
    Customer Service: (800) 778-8837
    Web site: http://www.totalsmallbone.com/

    Related medicine products :

    1. Avanta Trapezio-Metacarpal Prosthesis
    2. Avanta Total Wrist
    3. Skeletal Traction Pins, Full Pin with Cove Point
    4. Skeletal Traction Pins, Half Pin with Cove Point
    5. Meridional Implant (106 Style)
    6. Meridional Implant (103 Style)
    7. Meridional Implant (112 Style)
    8. Cylindrical Sponge Implants - 3.0 x 80 mm
    9. Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm
    10. Olk Design Sponge Implants - 7.5 x 2.75 x 80 mm
    11. Cylindrical Sponge Implants - 4.0 x 80 mm
    ...t consists of modular shavers and spreaders that r...d prepare the endplates for graft. The philosophy ...erbody fusion the disc and cartilaginous endplates...n of the disc space by 1mm steps in spreader width...
    The pedicle screw insertion assembly incorporates slotted guides for easy rod insertion and construct locking. The PathFinder MIS System uses an ingenious technique in which the pedicle screw inserti
    Kerrison (Spurling) Laminectomy Rongeur. 15 cm - 6, thick footplate, large handle, 90 up-cutting, 2 mm wide.
    Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide.
    Medicine Products:
    (Date:12/3/2008)...Breast-Specific Gamma Imaging (BSGI) has,equivale...MRI in patients with,inconclusive findings after ...east cancer, according to findings presented today...y of North America (RSNA). BSGI is a molecular bre...to mammography that can identify,lesions independ...
    (Date:12/3/2008)...RNewswire-FirstCall/ -- MAP,Pharmaceuticals, Inc....y, will,participate in a panel discussion titled ...ditions" at the 2008 RBC Capital Markets Healthcar...10:00 am (ET) in New York City. , A live we... the Investor,Relations section of MAP Pharmaceut...
    (Date:12/3/2008)... the blood thinner imported from China , ...eport on the deadly contamination of the blood thi...by a man-made chemical that was added to batches o... report. , The crisis, which began last Novembe...s 81 deaths in the United States. The Chinese hepa...
    (Date:12/3/2008)...wswire/ -- The gold coin tradition continues for T...been dropped into the red kettles, with the first ...05 Liberty $50 coin was wrapped in a $2 bill and d... Food Store in Norridge. , , Since the firs...2, The Salvation Army has seen gold coins of every...
    Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3
    ... a new study published in January 2007 issue of CA...tural changes in the cognitive areas of the brain....ancer-newsroom), a peer-reviewed journal of the Am...study have revealed that within 12 months of recei...
    ...ntists have developed a hormone-free contraceptive...or some hours.// The tablet, developed by research...fore sex and would prevent a man from being able t...tility would return to normal within a few hours, ...
    ...ch uses an electroencephalogram (EEG) to look for ...lect trait-like differences in emotionality and al...shed in the December issue of Alcoholism: Clinical...ings show an asymmetry of activities in the left a...
    ...n the Whanganui district of New Zealand has come i... happened following several errors in the hospital... to avail of specialist treatment. . Health Mini...essure to resign or to take urgent steps to improv...
    Other Medicine News:Health News:A New Research Explores Connection Between Emotionality And Alcoholism 2Health News:A New Research Explores Connection Between Emotionality And Alcoholism 3
    (Date:12/2/2008)...ec. 2 Micromet, Inc. (Na...ping novel, proprietary antibodies for the treatme..., today announced that it has entered into an agre...ility (CEFF) with Kingsbridge Capital Limited, a p...greement, Kingsbridge has committed to provide up ...
    (Date:12/1/2008)...1 TargeGen has announced that an o...ulti-center, US-based clinical,trial of TG101348 ...heduled at,the 2008 American Society of Hematolog...ation are as follows:, Title: A..., JAK2-Selective Inhibitor...
    (Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
    (Date:12/1/2008)...ll Scheduled for Tuesday, December 9 at 11:00 am E... , SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNe... (Nasdaq: SNSS ), a biopharmaceutical company fo...new oncology therapeutics, today announced new dat...eukemia (AML) will be presented during the 50th Am...
    Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Engineer receives 241 5M grant for nanoparticle cancer research 3825 1Research yields pricey chemicals from biodiesel waste 3823 1Research yields pricey chemicals from biodiesel waste 3823 2Research yields pricey chemicals from biodiesel waste 3823 3New Molecular Trigger Described for Hypertension Diabetes 22962 1New Molecular Trigger Described for Hypertension Diabetes 22962 2New Molecular Trigger Described for Hypertension Diabetes 22962 3From beach to backyard caution can reduce firepit burns 22960 1From beach to backyard caution can reduce firepit burns 22960 2
    ...SINESS WIRE)--Jul 10, 2007 - Corgenix Medical,Corp...collaborators,reported new clinical data demonstra...s of the Company,s patented AtherOx(TM),bio-marker...ed at,the XXIst Congress of the International Soci... Switzerland., Data released this week shows the a...
    ...ail to Demonstrate Meaningful Placebo Adjusted Wei...YORK, July 09, 2007 /PRNewswire-FirstCall/ -- Manh...s of the company,s two,Phase 2a clinical trials of...domized, double-blind, placebo-controlled studies,...sity, demonstrated no,statistically or clinically ...
    Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4